Display options
Share it on

Br J Radiol. 2016 Aug;89(1064):20151060. doi: 10.1259/bjr.20151060. Epub 2016 May 26.

Current strategies in interventional oncology of colorectal liver metastases.

The British journal of radiology

Tatjana Gruber-Rouh, Christian Marko, Axel Thalhammer, Nour-Eldin Nour-Eldin, Marcel Langenbach, Martin Beeres, Nagy N Naguib, Stephan Zangos, Thomas J Vogl

Affiliations

  1. 1 Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.
  2. 2 Department of Radiology, Faculty of Medicine (Kasr Al-Ainy), Cairo University, Alexandria, Egypt.
  3. 3 Department of Radiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

PMID: 27164030 PMCID: PMC5124876 DOI: 10.1259/bjr.20151060

Abstract

The adequate treatment of non-resectable liver metastases from colorectal cancer which are resistant to systemic chemotherapy currently provides a great challenge. The aim is to identify and review key strategies in the treatment of colorectal liver metastases. A search for current literature on the topic of interventional strategies for colorectal metastases was performed in Medline in order to achieve this goal. Studies before 2005 and with <20 patients treated for colorectal metastases were excluded. Transarterial chemoembolization (TACE), transarterial embolization and selective internal radiation therapy (SIRT) were identified as examples of regional strategies for colorectal liver metastases, utilizing the unique blood supply of the liver. Radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation were selected as examples for currently available ablative techniques. Median survival in the key studies reviewed ranged from 7.7 to 28.6 for TACE, 8.3-12.6 for SIRT, 8.2-53.2 for RFA and 29-43 months for MWA. After review of the literature, it can be concluded that interventional oncologic therapies are a safe and effective method for treating colorectal liver metastases. The use of new chemotherapeutic agents for local therapy and new ablation technologies and techniques may increase patient survival and allows a neoadjuvant therapy setting. In addition, a combination of local therapies may be used to increase effectiveness in the future, which is subject to further research.

References

  1. J Gastrointest Surg. 2009 Feb;13(2):318-24 - PubMed
  2. HPB Surg. 2013;2013:570808 - PubMed
  3. Am J Surg. 2009 Jun;197(6):728-36 - PubMed
  4. J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S104-11 - PubMed
  5. Anticancer Res. 2011 Dec;31(12 ):4581-7 - PubMed
  6. Acta Oncol. 2013 Jun;52(5):971-7 - PubMed
  7. Rofo. 2011 Jan;183(1):12-23 - PubMed
  8. Ann Surg Oncol. 2010 Jan;17(1):171-8 - PubMed
  9. Acta Radiol. 2009 Sep;50(7):716-21 - PubMed
  10. Semin Intervent Radiol. 2013 Mar;30(1):12-20 - PubMed
  11. Abdom Imaging. 2005 Jul-Aug;30(4):419-26 - PubMed
  12. Clin Colon Rectal Surg. 2009 Nov;22(4):191-7 - PubMed
  13. J Surg Oncol. 2014 Aug;110(2):182-96 - PubMed
  14. Ann Surg. 2014 Jun;259(6):1195-200 - PubMed
  15. World J Gastroenterol. 2015 Mar 21;21(11):3300-7 - PubMed
  16. Acta Chir Belg. 2014 Jan-Feb;114(1):40-5 - PubMed
  17. J Surg Oncol. 2007 Nov 1;96(6):481-6 - PubMed
  18. Eur Radiol. 2007 Apr;17(4):1025-34 - PubMed
  19. Oncologist. 2003;8(6):553-66 - PubMed
  20. J Vasc Interv Radiol. 2009 Mar;20(3):360-7 - PubMed
  21. World J Gastrointest Surg. 2015 Mar 27;7(3):33-8 - PubMed
  22. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):412-25 - PubMed
  23. Br J Cancer. 2012 Mar 27;106(7):1274-9 - PubMed
  24. Semin Oncol. 2002 Apr;29(2):107-18 - PubMed
  25. Cardiovasc Intervent Radiol. 2012 Oct;35(5):1066-73 - PubMed
  26. Arch Surg. 2008 Dec;143(12):1204-12 - PubMed
  27. Hepatol Res. 2012 Nov;42(11):1058-64 - PubMed
  28. J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S112-21 - PubMed
  29. Surg Endosc. 2010 Feb;24(2):254-65 - PubMed
  30. Radiology. 1983 Aug;148(2):397-401 - PubMed
  31. J Vasc Interv Radiol. 2014 Jul;25(7):1012-7 - PubMed
  32. Cardiovasc Intervent Radiol. 2012 Aug;35(4):868-74 - PubMed
  33. Cardiovasc Intervent Radiol. 1999 Jul-Aug;22(4):293-7 - PubMed
  34. J Clin Gastroenterol. 2008 Sep;42(8):945-9 - PubMed
  35. J Surg Oncol. 2005 Apr 1;90(1):36-42 - PubMed
  36. Anticancer Res. 2012 Apr;32(4):1387-95 - PubMed
  37. Eur J Surg Oncol. 2006 May;32(4):430-4 - PubMed
  38. J Med Imaging Radiat Oncol. 2014;58(3):341-52 - PubMed
  39. Radiology. 2009 Jan;250(1):281-9 - PubMed
  40. Radiology. 2013 Feb;266(2):407-30 - PubMed
  41. Ann Surg Oncol. 2008 Jan;15(1):227-32 - PubMed
  42. Radiologe. 2015 Jan;55(1):48-52 - PubMed
  43. Eur J Gastroenterol Hepatol. 2009 Jun;21(6):599-605 - PubMed
  44. J Vasc Interv Radiol. 2009 Feb;20(2):203-8 - PubMed
  45. Br J Cancer. 2010 Jul 27;103(3):324-31 - PubMed
  46. HPB (Oxford). 2007;9(2):120-4 - PubMed
  47. Radiol Med. 2003 Apr;105(4):350-5 - PubMed
  48. Arch Surg. 2006 May;141(5):460-6; discussion 466-7 - PubMed
  49. Cancer. 2011 Jan 15;117(2):343-52 - PubMed
  50. Acta Radiol. 2007 Apr;48(3):253-8 - PubMed
  51. Radiology. 2012 Dec;265(3):958-68 - PubMed

Publication Types